Skip to main content
. 2011 May 30;2011:621839. doi: 10.4061/2011/621839

Table 1.

Patients characteristics and cytological, pathological, and biochemical data.

Patients Histology pTNM Duration (months) Tg (ng/mL) TgAb (IU/mL) Lesions  Sites FNA Final diagnosis
Cytology Tg (ng/mL)
1 PTC pT1N1Mx 6 1.0 <60 1 R II ND <0.2 B
2 PTC pT1NxMx 15 4.6 <60 1 L III Negative 435.2 M
3 PTC pT1NxMx 18 1.7 <60 1 R IV CTM 85.3 M
4 PTC pT1NxMx 30 0.4 <60 1 R III ND <0.2 B
5 PTC pT1N0Mx 6 3.1 <60 1 L II ND 97.2 M
6 PTC pT2N0Mx 19 9.1 <60 2 R IV, VI CTM 118.5 M
7 PTC pT2NxMx 47 <0.2 334 1 L IV CTM 879.4 M
8 PTC pT2N1Mx 6 0.9 78 1 VI Negative 1.1 B
9 PTC pT1N1Mx 9 9.8 <60 1 L II ND 1348.6 M
10 PTC pT2N0Mx 14 1.5 <60 1 L III CTM 358.5 M
11 PTC pT1NxMx 8 12.6 <60 3 R II CTM 2387.4 M
12 PTC pT2NxMx 16 9.7 <60 1 R III CTM 875.9 M
13 PTC pT1NxMx 9 6.3 <60 1 R II CTM 958.6 M
14 PTC pT1N0Mx 11 1.0 <60 1 L III Negative 48.7 M
15 PTC pT2N1Mx 39 9.5 <60 1 L IV CTM >3000 M
16 PTC pT1NxMx 12 0.8 <60 1 L III CTM 107.5 M
17 PTC pT2NxMx 19 2.7 <60 3 R III-IV ND, CTM 541.6 RIII B, IV M
18 PTC pT4N1Mx 6 1.6 <60 1 L III CTM 31.8 M
19 PTC pT1N1Mx 15 0.5 289 1 R IV ND <0.2 B
20 PTC pT2N1Mx 3 2.3 <60 1 L III ND 540.7 M
21 PTC pT1NxMx 34 4.1 <60 1 L III CTM 650.6 M
22 PTC pT2N1Mx 8 <0.2 98 1 L II ND 5.8 M
23 PTC pT1NxMx 9 0.8 <60 2 R II, R III CTM 87.5 M
24 PTC pT4N0Mx 10 1.4 755 1 R II CTM 196.4 M
25 PTC pT2NxMx 21 11 <60 1 R III ND 585.3 M
26 PTC pT1NxMx 9 <0.2 <60 1 R III Negative <0.2 B
27 PTC pT4N1M 12 1.1 160 1 L III Negative 0.3 B
28 PTC pT1N0Mx 23 5.3 <60 1 R III CTM 784.2 M
29 PTC pT2N1Mx 5 <0.2 >1000 1 R III ND <0.2 B
30 PTC pT2N0Mx 22 4.9 <60 1 R III CTM 641.5 M
31 PTC pT1NxMx 36 0.3 367 1 R IV Negative <0.2 B
32 PTC pT1NxMx 15 7.1 <60 1 R III ND 665.4 M
33 PTC pT2N0Mx 41 <0.2 <60 1 L II Negative <0.2 B
34 PTC pT1NxMx 24 2.6 <60 1 R III CTM 570.6 M
35 PTC pT4N0Mx 31 1.4 >1000 3 L IV, VI CTM 96.7 M
36 PTC pT4N1M 12 27.1 <60 1 R II CTM 2987.3 M
37 PTC pT1N1Mx 54 6.8 <60 1 L III CTM 875.6 M
38 PTC pT2NxMx 12 <0.2 149 1 R IV Negative <0.2 B
39 PTC pT2N0Mx 9 0.9 <60 1 R II Negative <0.2 B
40 PTC pT1N0Mx 34 2.4 89 1 L III ND 347.4 M
41 PTC pT2NxMx 14 5.1 <60 1 L IV ND 1655.7 M
42 PTC pT4N1M 8 7.7 <60 1 L III Negative 2076.5 M
43 PTC pT1NxMx 61 1.1 <60 1 VI Negative <0.2 B
44 PTC pT2N0Mx 22 1.0 <60 1 L II CTM 90.6 M
45 PTC pT2N1Mx 12 6.4 <60 2 R III-IV CTM, ND 458.6 RIII M, IV B
46 PTC pT1NxMx 45 0.6 <60 1 R IV Negative <0.2 B
47 PTC pT4N0Mx 36 4.3 <60 1 R III CTM 766.4 M
48 PTC pT2NxMx 11 1.9 <60 1 L II ND 306.5 M
49 PTC pT3NxMx 18 7.0 <60 1 R III CTM 955.6 M
50 PTC pT2NxMx 10 1.2 <60 1 L III Negative <0.2 B
51 PTC pT1N1Mx 12 3.9 <60 1 R III CTM 564.7 M
52 PTC pT3N0Mx 25 6.4 190 1 R III ND 1078.6 M
53 PTC pT2N1Mx 16 9.5 <60 1 L IV CTM 759.4 M
54 PTC pT1NxMx 9 0.6 <60 1 R III Negative <0.2 B
55 PTC pT3N1Mx 60 <0.2 107 2 L II-III CTM 137.5 M
56 PTC pT1N0Mx 11 5.3 <60 1 R II CTM 654.8 M
57 PTC pT2N1Mx 18 1.1 860 1 L III ND <0.2 B
58 PTC pT1NxMx 9 0.9 <60 1 R IV Negative <0.2 B
59 PTC pT2NxMx 28 1.1 <60 1 R III ND 99.6 M
60 PTC-TCV pT3NxMx 13 4.6 <60 1 L II CTM 436.8 M
61 PTC pT1NxMx 2 2.7 <60 1 R II CTM 194.5 M
62 PTC pT3NxMx 7 21.9 <60 3 R III, L II Neg., CTM >3000 RIII B, LII M
63 PTC pT1NxMx 18 1.1 <60 1 R III CTM 27.4 M
64 PTC pT3NxMx 10 3.5 <60 1 VI CTM 147.4 M
65 PTC pT2N0Mx 29 <0.2 >1000 1 R IV Negative <0.2 B
66 PTC pT3N1Mx 6 5.6 <60 1 L III CTM <0.2 M
67 PTC pT1N1Mx 11 2.1 <60 1 R III ND <0.2 M
68 PTC pT3N0Mx 18 0.7 <60 1 R III ND <0.2 B
69 PTC pT2N0Mx 23 1.7 <60 1 L IV CTM 75.6 M
70 PTC pT1NxMx 9 3.5 <60 1 L II ND 72.6 M
71 PTC pT3N0Mx 18 7.1 <60 2 R IV, VI CTM 386.2 RIV B, VI M
72 PTC pT1NxMx 7 1.8 1 L II Negative <0.2 B
73 PTC pT2NxMx 11 3.6 <60 1 R III ND 245.7 M
74 PTC pT2NxMx 29 2.2 <60 2 L III-IV CTM 67.4 IV M, III B
75 PTC pT2N1Mx 14 5.7 <60 1 L II CTM 198.7 M
76 PTC pT1N0Mx 8 1.5 <60 1 R IV CTM 26.1 M
77 PTC pT2NxMx 10 2.1 <60 1 VI CTM 59.7 M
78 PTC pT1NxMx 18 0.7 <60 1 R IV Negative <0.2 B
79 PTC pT3N1Mx 34 12.3 <60 1 R III ND 678.4 M
80 PTC pT1N1Mx 16 1.8 <60 1 L II Negative <0.2 B
81 PTC pT2N0Mx 52 0.9 <60 1 R III Negative <0.2 B
82 PTC pT2N1Mx 25 9.4 <60 1 L III ND 563.6 M
83 PTC pT1NxMx 9 4.1 <60 1 VI CTM 64.7 M
84 PTC pT2N1Mx 18 3.1 <60 1 R IV CTM 116.4 M
85 PTC-TCV pT2NxMx 20 15.5 <60 3 R IV-L III CTM 432.9 M
86 PTC pT3N0Mx 8 <0.2 56 1 VI ND <0.2 B
87 PTC pT1N0Mx 31 2.9 <60 1 R IV CTM 39.3 M
88 PTC pT2NxMx 11 1.7 <60 1 R III Negative <0.2 B
89 PTC pT2NxMx 54 6.5 <60 1 L IV ND 467.7 M
90 PTC pT1N1Mx 28 0.3 651 1 R II Negative <0.2 B
91 PTC pT2NxMx 12 2.1 <60 1 L III CTM 88.6 M
92 PTC pT3N0Mx 17 9.4 <60 2 R IV, VI CTM 156.2 IV M, VI B
93 PTC pT1NxMx 22 1.0 <60 1 L IV Negative <0.2 B
94 PTC pT2N1Mx 9 4.3 <60 1 VI Negative 53.8 M
95 PTC pT2N0Mx 26 <0.2 <60 1 R IV Negative <0.2 B
96 PTC pT1N0Mx 12 0.9 <60 1 R III ND 2.7 M
97 PTC pT2NxMx 17 8.1 <60 1 L II ND 356.4 M
98 PTC pT2NxMx 9 0.9 <60 1 R III CTM 19.6 M
99 PTC pT3N1Mx 12 1.1 <60 1 L III ND 0.6 B
100 FTC pT1N1Mx 45 4.9 <60 1 R III CTM 117.5 M
101 FTC pT3N0Mx 36 1.4 <60 1 R III Negative <0.2 B
102 FTC pT2N1Mx 11 <0.2 >1000 2 R III-IV Negative <0.2 B
103 FTC (HC) pT1NxMx 72 10.4 <60 1 R IV ND 278.9 M
104 FTC pT2N1Mx 11 0.7 <60 1 R III Negative <0.2 B
105 FTC pT1N0Mx 18 2.1 <60 1 R IV CTM 74.4 M
106 FTC (HC) pT1N0Mx 6 1.9 <60 1 L III Negative 0.8 B
107 FTC pT2N1Mx 25 7.8 <60 1 R II ND 116.4 M
108 FTC pT1NxMx 19 4.6 <60 2 L II-III CTM 89.5 M

FNA, fine-needle aspiration; PTC, papillary thyroid carcinoma; FTC, follicular thyroid carcinoma; TCV, tall-cell variant; HC Hürtle cell; R, right, L, left; duration, time from thyroid ablation to FNA; II-III-IV, upper, middle, lower neck lateral compartment, IV, central neck compartment.